Use of antiresorptive agents for osteoporosis management

Publication

Release Date: 26 Aug 2011

Topic: Chronic musculoskeletal conditions

Media release

AIHW

Australian Institute of Health and Welfare (2011) Use of antiresorptive agents for osteoporosis management, AIHW, Australian Government, accessed 02 June 2023.

APA

Australian Institute of Health and Welfare. (2011). Use of antiresorptive agents for osteoporosis management. Canberra: AIHW.

MLA

Australian Institute of Health and Welfare. Use of antiresorptive agents for osteoporosis management. AIHW, 2011.

Vancouver

Australian Institute of Health and Welfare. Use of antiresorptive agents for osteoporosis management. Canberra: AIHW; 2011.

Harvard

Australian Institute of Health and Welfare 2011, Use of antiresorptive agents for osteoporosis management, AIHW, Canberra.

PDF | 776Kb

Other formats

Download publication

Enter the email address where you would like the PDF sent. This address will not be used for any other purpose.

There is no cure for osteoporosis but antiresorptive drugs can reduce further bone loss and slow down disease progression. This report provide information on both the individual and community use of antiresorptive drugs for managing osteoporosis as well as trends in the supply of and expenditure for these medications.

ISBN: 978-1-74249-192-9
Cat. no: PHE 148
Pages: 48

Preliminary material
- Title and verso pages
- Contents
- Acknowledgments
- Summary
Body section
1. Introduction
- - What is osteoporosis?
  - The extent of the problem
  - Osteoporosis and bone remodelling
  - Antiresorptives available in 2003–07
  - Compliance with antiresorptive therapy
  - Questions addressed in this study
  - Structure and aims of the report
1. The study design
- - Pharmaceutical Benefits Scheme
  - Antiresorptives monitored
  - Cohort selection
1. Initiation of antiresorptive therapy
- - Demographic characteristics of initiating cohort
  - The first prescribed antiresorptive
  - Prescribers
  - Time taken to fill the first prescription
1. The first 12 months of antiresorptive supply
- - How many prescribers?
  - Drug switching
  - Were enough antiresorptives supplied in the first 12 months?
1. Discussion
- - Key findings
End matter
- Appendix A PBS data
- Appendix B The study cohorts
- References
- List of tables
- List of figures

Use of antiresorptive agents for osteoporosis management

Citation

AIHW

APA

MLA

Vancouver

Harvard

Table of contents

AIHW

Connect with us

Feedback